CLINICAL_TRIALS
trial_result
· 2025-08-08
Clinical Trial Update: Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. [Phase 2]
Summary
Phase 2 trial update evaluating intensified treatment with carfilzomib in multiple myeloma patients who remain PET-positive after first-line therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oslo University Hospital | Conditions: Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING